Search results
Results from the WOW.Com Content Network
Jigglypuff (/ ˈ dʒ ɪ ɡ l i p ʌ f / ⓘ JIG-lee-puf), known in Japan as Purin (Japanese: プリン), [5] is a Pokémon species. Jigglypuff first appeared in the video games Pokémon Red and Blue and subsequent sequels, later appearing in various merchandise, spinoff titles and animated and printed adaptations of the franchise.
Infection rates dropped and stabilised throughout 2022 and 2023, leading to the end of COVID-19's classification as a severe transmissible disease in June 2023. [22] Although the pandemic has heavily disrupted the country's economy, [23] Vietnam's GDP growth rate has remained one of the highest in Asia-Pacific, at 2.91% in 2020. Due to the more ...
The Việt Á scandal was a bribery and corruption scandal that arose during the COVID-19 pandemic in Vietnam. In 2020 and 2021, Việt Á Technology Corporation [ vi ] bribed Vietnamese government officials to sell COVID-19 RT-PCR tests , at a heavy mark-up to provincial health departments and hospitals.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
A police car in Hanoi with COVID-19 public health messaging. The Vietnamese government using social media platforms to keep the public informed of COVID-19 news and instructions. Thong Tin Chinh Phu (Governmental Information), the government's official Facebook page, provides nearly hourly updates on the country's pandemic situation. Zalo, a ...
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
COVID-19 is the deadliest pandemic in US history; [360] it was the third-leading cause of death in the US in 2020, behind heart disease and cancer. [361] From 2019 to 2020, US life expectancy dropped by 3 years for Hispanic Americans, 2.9 years for African Americans, and 1.2 years for white Americans. [362]
The phase III study is the adaptive, multicenter, randomized, double-blind, placebo control study to evaluate the safety, immunogenicity, and efficacy of the Nanocovax vaccine against COVID-19 in volunteer subjects 18 years of age and older. [17]